Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Blood Advances|July 25, 2018
CLT030, a leukemic stem cell-targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemiaYing-Ping Jiang, Bob Y Liu, Quan Zheng, et al.
Mabs|October 15, 2013
An improved and robust DNA immunization method to develop antibodies against extracellular loops of multi-transmembrane proteinsMeredith Hazen, Sunil Bhakta, Rajesh Vij, et al.
The Journal of Biological Chemistry|September 6, 2015
Kinome Screen Identifies PFKFB3 and Glucose Metabolism as Important Regulators of the Insulin/Insulin-like Growth Factor (IGF)-1 Signaling PathwaySophie Trefely, Poh-Sim Khoo, James R Krycer, et al.
NPJ Systems Biology and Applications|July 21, 2017
Cross-species gene expression analysis identifies a novel set of genes implicated in human insulin sensitivityRima Chaudhuri, Poh Sim Khoo, Katherine Tonks, et al.
Journal of Medicinal Chemistry|October 18, 2013
Enhanced tumor retention of a radiohalogen label for site-specific modification of antibodiesC Andrew Boswell, Jan Marik, Michael J Elowson, et al.
Diabetologia|April 23, 2015
Subcutaneous fat transplantation alleviates diet-induced glucose intolerance and inflammation in miceSamantha L Hocking, Rebecca L Stewart, Amanda E Brandon, et al.
Blood|July 28, 2009
Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphomaDavid Dornan, Fiona Bennett, Yvonne Chen, et al.
Bioconjugate Chemistry|February 10, 2018
High-Throughput Cysteine Scanning To Identify Stable Antibody Conjugation Sites for Maleimide- and Disulfide-Based LinkersRachana Ohri, Sunil Bhakta, Aimee Fourie-O'Donohue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2010
Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancerJagath R Junutula, Kelly M Flagella, Richard A Graham, et al.
Molecular Cancer Therapeutics|December 29, 2017
An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast CancerSunil Bhakta, Lisa M Crocker, Yvonne Chen, et al.
Pageof 5